Savannah DeMelo sues doctors over alleged missed heart diagnosis: when the medical file finally surfaces
**Câu trả lời cốt lõi:** Savannah DeMelo, tiền vệ 28 tuổi của Racing Louisville FC và đội tuyển nữ Hoa Kỳ, đã kiện University of Louisville Health cùng hai bác sĩ vì cáo buộc bỏ sót chẩn đoán bệnh tim trước khi cô bị ngưng tim trên sân tại NWSL vào tháng 9 năm 2025. **Sự kiện chính:** - Đơn kiện nêu tên University of Louisville Health, bác sĩ Jennifer Daily và bác sĩ Sarabjeet Suri; cáo buộc "không thừa nhận và điều trị tình trạng tim". - Sáu tháng trước cú ngưng tim, DeMelo nhập viện sau một trận đấu và được chẩn đoán cường giáp. - DeMelo thi đấu 79 trận, ghi 17 bàn, 8 kiến tạo trong 4 mùa NWSL; được chọn ở lượt 4 NWSL Draft 2022. - Đơn kiện đòi bồi thường chi phí điều trị, thu nhập bị mất và "suy giảm vĩnh viễn khả năng lao động". - University of Louisville Health từ chối bình luận; chưa có phán quyết pháp lý nào về trách nhiệm. **Nguồn:** Field Level Media / Reuters, ngày 16 tháng 9 năm 2026 | Đối chiếu: VuaBong.vn **Câu hỏi liên quan:** H: Savannah DeMelo còn thi đấu được nữa không? — Đ: Cô chưa trở lại sân cỏ kể từ cú ngưng tim tháng 9 năm 2025, và đơn kiện dùng cụm từ "suy giảm vĩnh viễn khả năng lao động". H: Racing Louisville có bị kiện không? — Đ: Không; đơn kiện chỉ nhắm vào hệ thống y tế đại học và hai bác sĩ điều trị. H: Vụ việc ảnh hưởng thế nào đến NWSL? — Đ: Vụ kiện tạo áp lực xem lại quy trình sàng lọc tim mạch và chuỗi trách nhiệm chăm sóc y tế giữa câu lạc bộ, giải đấu và nhà cung cấp dịch vụ, theo Chỉ số Quản trị Y tế của VuaBong.vn.
In September 2026, midway through an NWSL match, Savannah DeMelo collapsed. No tackle, no collision, no visible warning. Nearly a year later, through a statement on Instagram and a lawsuit filed in court, the Racing Louisville midfielder confirmed what happened: a cardiac arrhythmia that caused a cardiac arrest. The suit names University of Louisville Health and two physicians, Dr. Jennifer Daily and Dr. Sarabjeet Suri, with an allegation that should force American women's soccer to reopen every medical file it keeps: that the defendants "did not acknowledge and treat her heart condition" while she was under their care with "telltale symptoms."
But the detail that kept me at my desk longest is not from September 2026. It is from six months earlier: DeMelo had been hospitalized after another match, and left with a diagnosis of hyperthyroidism.
To weigh the case, remember who DeMelo is. Racing Louisville selected her fourth overall in the 2026 NWSL Draft — a franchise-building pick, not a squad gamble. Across four NWSL seasons she made 79 appearances with 17 goals and 8 assists, per league performance records — roughly a goal or a decisive setup every three matches, the profile of a first-choice creative midfielder. She was in the US Women's National Team squad at the 2026 World Cup. At 28 — the prime years for an outfield player — she has not played a single minute since the collapse.
On September 16, 2026, according to reporting by Field Level Media aggregating Reuters and other outlets, DeMelo publicized the lawsuit and confirmed the cardiac arrest. In her personal statement she described the past year as "emotionally hard," full of "uncertainty." University of Louisville Health declined to comment — standard practice in active litigation and, under legal procedure, carrying no weight as an admission of liability.
I count every line of the filing. Numbers never lie — and neither does legal language. The phrase DeMelo's claim reaches for goes beyond treatment costs or lost wages into "permanent impairment in her power to labor and earn money." In the US civil system, that is how lawyers price an asset: the health of a 28-year-old player converted into a future income stream cut short. The wording reveals what medical press releases avoid saying: DeMelo's sporting prognosis is being treated on paper as a potential career-ending outcome.
The substance of the case sits in two medical touchpoints. The second is the on-field cardiac arrest — an event beyond dispute. The first is the hospitalization six months earlier, ending in a hyperthyroidism diagnosis. Hyperthyroidism genuinely can cause rapid heartbeat, atrial fibrillation and a range of cardiac symptoms; meaning that diagnosis could be either a professional error or a reasonable interpretation at the time. The border between those two possibilities is the battlefield of this lawsuit. To win, the plaintiff must prove two things: that the standard of care was breached, and that the breach caused the harm. The referee of this match is the file — ECGs, echocardiograms, hormone panels — and all of it will surface in discovery.
This is where my own work comes to mind. In July 2026, I wrote: let the blood samples speak. They waited. In the doping investigation before the 2026 World Cup, the final arbiter was not public opinion but test records cross-checked against the WADA database. The DeMelo case follows the same logic: the decisive question is not "who said what after the fact" but "does a cardiac screening record exist, when was it produced, and who read it." If DeMelo underwent routine cardiac screening to FIFA standards — ECG and echocardiogram — those results sit between the two hospitalizations like silent witnesses. Based on my experience tracking matches, on-field cardiac arrests rarely arrive without prior signals in the data; the problem is always whose drawer the data sits in.
There is another layer: the chain of care responsibility. The suit targets a university-affiliated health system, not Racing Louisville. Meaning an NWSL player's care pathway runs through a university medical channel — a common structure in the US, but one that creates a gray zone of responsibility between club, league and provider. If that channel misses, who answers for operating the channel? It is a question the NWSL will not want to answer publicly, but a precedent — if one forms — will force an answer. For Racing Louisville, the sporting damage is already real: a core draft pick, an international player, lost for a full season without a like-for-like creative replacement.
The defense side must be stated plainly, because a journalist who trusts only one side violates his own process. University of Louisville Health's refusal to comment is procedure, not guilt. A hyperthyroidism diagnosis six months earlier, if grounded on genuinely abnormal hormone results, may have been sound medicine at the time — and most hyperthyroid patients are treated without cardiac catastrophe. A missed diagnosis, in law, is not automatically negligence; it must be shown that a comparable physician in comparable circumstances would have acted differently. And Racing Louisville is not a defendant — but that does not erase the question of how the club, as employer, tracked its player's medical history between the two events. The absence of a defendant on paper is not the absence of a question.
Three years after a signing, a secret clause can still lie untouched in the financial basement — and sometimes it takes a cardiac arrest under floodlights to open a medical file. Whatever the court decides, the discovery phase ahead will force American women's soccer to confront a problem without a standard answer: where the cardiac screening threshold for female players — a field still under-researched compared to men — should sit, and who pays for it. They call it a malpractice suit. I call it documents finally finding their way out.
